Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuous -time Fourier Transform01:11

Continuous -time Fourier Transform

897
The Fourier series is instrumental in representing periodic functions, offering a powerful method to decompose such functions into a sum of sinusoids. This technique, however, necessitates modification when applied to nonperiodic functions. Consider a pulse-train waveform consisting of a series of rectangular pulses. When these pulses have a finite period, they can be accurately represented by a Fourier series. Yet, as the period approaches infinity, resulting in a single, isolated pulse, the...
897
Basic Continuous Time Signals01:22

Basic Continuous Time Signals

683
Basic continuous-time signals include the unit step function, unit impulse function, and unit ramp function, collectively referred to as singularity functions. Singularity functions are characterized by discontinuities or discontinuous derivatives.
The unit step function, denoted u(t), is zero for negative time values and one for positive time values, exhibiting a discontinuity at t=0. This function often represents abrupt changes, such as the step voltage introduced when turning a car's...
683
Sampling Continuous Time Signal01:11

Sampling Continuous Time Signal

737
In signal processing, a continuous-time signal can be sampled using an impulse-train sampling technique, followed by the zero-order hold method. Impulse-train sampling involves the use of a periodic impulse train, which consists of a series of delta functions spaced at regular intervals determined by the sampling period. When a continuous-time signal is multiplied by this impulse train, it generates impulses with amplitudes corresponding to the signal's values at the sampling points.
In the...
737
BIBO stability of continuous and discrete -time systems01:24

BIBO stability of continuous and discrete -time systems

915
System stability is a fundamental concept in signal processing, often assessed using convolution. For a system to be considered bounded-input bounded-output (BIBO) stable, any bounded input signal must produce a bounded output signal. A bounded input signal is one where the modulus does not exceed a certain constant at any point in time.
To determine the BIBO stability, the convolution integral is utilized when a bounded continuous-time input is applied to a Linear Time-Invariant (LTI) system....
915
Continuing Care01:25

Continuing Care

1.9K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.9K
Continuity Equation01:28

Continuity Equation

3.3K
The continuity equation asserts that the mass flow rate must remain constant for a steady flow of an incompressible fluid within a confined system. This principle applies to systems where fluid passes through varying cross-sectional areas, such as nozzles, syringes, and pipes.
The mass flow rate is expressed as:
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Interactive Pharmacokinetic-Pharmacodynamic Framework to Evaluate Bedaquiline Dose Modifications in Adults With Tuberculosis.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Learning Covariate Relations in Disease Progression Models Using Symbolic Neural Networks.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Weight-band-based simplification of oral allometric miltefosine dosing in paediatric patients with visceral leishmaniasis.

The Journal of antimicrobial chemotherapy·2026
Same author

Model-informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis.

British journal of clinical pharmacology·2026
Same author

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.

EClinicalMedicine·2026
Same author

Addressing Causality and Homogeneity Assumptions in Exposure-Response Analyses.

Clinical pharmacology and therapeutics·2025
Same journal

Updated Recommendations for the Bioanalysis of Antibody-Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community.

The AAPS journal·2026
Same journal

In vivo Predictive Dissolution Test Using Biorelevant Bicarbonate Buffer for High-dose Free Acid Drug.

The AAPS journal·2026
Same journal

Whole-Body Pharmacokinetics of Ionizable Lipid, mRNA, and the Expressed Antibody following Intravenous Administration of mRNA-Loaded Lipid Nanoparticles.

The AAPS journal·2026
Same journal

Simple Hydrodynamic Molecular Weight Model for Rapid Assessment of Therapeutic Protein Oligomerization States in Formulation.

The AAPS journal·2026
Same journal

Guiding the Molnupiravir Tablet Formulation Using Physiologically Based Biopharmaceutics Modeling and Successfully Establishing Dissolution Safe Space.

The AAPS journal·2026
Same journal

Correction: Nanotechnology-enhanced Natural Products for Cancer Chemoprevention: Molecular Mechanisms and Clinical Translation.

The AAPS journal·2026
See all related articles

Related Experiment Video

Updated: Jan 28, 2026

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.6K

A Minimal Continuous-Time Markov Pharmacometric Model.

Emilie Schindler1, Mats O Karlsson2

  • 1Department of Pharmaceutical Biosciences, Uppsala University, Box 591, SE-75124, Uppsala, Sweden.

The AAPS Journal
|June 22, 2017
PubMed
Summary
This summary is machine-generated.

A new minimal continuous-time Markov model (mCTMM) analyzes ordered categorical data. It simplifies Markov properties using mean equilibration time, offering a flexible alternative to standard models for complex datasets.

Keywords:
NONMEMnon-linear mixed effects modelsordered categorical datapharmacokinetic-pharmacodynamicserial correlations

More Related Videos

Continuous Measurement of Biological Noise in Escherichia Coli Using Time-lapse Microscopy
08:25

Continuous Measurement of Biological Noise in Escherichia Coli Using Time-lapse Microscopy

Published on: April 27, 2021

4.1K
Autonomously Bioluminescent Mammalian Cells for Continuous and Real-time Monitoring of Cytotoxicity
04:47

Autonomously Bioluminescent Mammalian Cells for Continuous and Real-time Monitoring of Cytotoxicity

Published on: October 28, 2013

10.5K

Related Experiment Videos

Last Updated: Jan 28, 2026

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.6K
Continuous Measurement of Biological Noise in Escherichia Coli Using Time-lapse Microscopy
08:25

Continuous Measurement of Biological Noise in Escherichia Coli Using Time-lapse Microscopy

Published on: April 27, 2021

4.1K
Autonomously Bioluminescent Mammalian Cells for Continuous and Real-time Monitoring of Cytotoxicity
04:47

Autonomously Bioluminescent Mammalian Cells for Continuous and Real-time Monitoring of Cytotoxicity

Published on: October 28, 2013

10.5K

Area of Science:

  • Biostatistics
  • Statistical Modeling
  • Data Analysis

Background:

  • Analyzing ordered categorical data with Markov properties often requires complex models like discrete-time Markov models (DTMM) or standard continuous-time Markov models (CTMM).
  • Existing models may face limitations with non-uniform observation times or a large number of categories.
  • There is a need for a more parsimonious yet effective model for such data.

Purpose of the Study:

  • To introduce and evaluate the minimal continuous-time Markov model (mCTMM) as an alternative for analyzing ordered categorical data with Markov properties.
  • To demonstrate the mCTMM's ability to simplify Markov property representation and integrate with proportional odds (PO) models for steady-state probabilities.
  • To assess the mCTMM's performance against existing models using real-world patient data.

Main Methods:

  • Developed the minimal CTMM (mCTMM) by reparameterizing CTMM, assuming transition rates are state-independent.
  • Expressed Markov property via mean equilibration time and steady-state probabilities via a proportional odds (PO) model.
  • Compared mCTMM performance against PO models and published Markov models using fatigue and pain score datasets.

Main Results:

  • mCTMM provided a better fit to the data than the PO model (ignoring Markov features) across all examples.
  • mCTMM accurately predicted average transitions and maximum achieved scores, outperforming a count model for Likert data.
  • While less flexible than DTMM, mCTMM required fewer parameters and demonstrated applicability with non-uniform time intervals and numerous categories.

Conclusions:

  • The mCTMM offers a valuable, parsimonious approach for analyzing ordered categorical data with Markov properties, especially when standard models are challenging to implement.
  • This model facilitates the exploration of predictive factors like drug exposure and covariates while accounting for underlying Markovian dynamics.
  • mCTMM serves as a practical alternative for complex datasets where DTMM or standard CTMM may not be suitable.